| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.40B | +19.4% |
| Cost of Revenue | $441.7M | +20.3% |
| Gross Profit | $960.8M | +19.0% |
| R&D Expense | $178.3M | +8.7% |
| SG&A Expense | $187.4M | -2.3% |
| Operating Income | $260.1M | +67.8% |
| Pre-tax Income | $277.0M | +74.6% |
| Income Tax | $70.2M | +294.8% |
| Net Income | $206.8M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $401.8M | +39.1% |
| Accounts Receivable | $33.0M | +31.5% |
| Current Assets | $3.52B | +15.6% |
| Total Assets | $4.25B | +14.9% |
| Current Liabilities | $3.12B | +12.3% |
| Total Liabilities | $3.21B | +12.6% |
| Stockholders' Equity | $1.03B | +22.6% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $384.7M | +36.1% |
| Capital Expenditures | $18.0M | -17.7% |
| Investing Cash Flow | -$101.9M | +53.7% |
| Financing Cash Flow | $141.6M | +109.9% |
| Free Cash Flow | $366.6M | +40.6% |
| +46.8% |
| EPS (Basic) | $3.68 | +45.5% |
| EPS (Diluted) | $3.63 | +45.8% |